hims wegovy - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

CBS News on MSN · 4d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

NJBIZ · 21h

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

2hon MSN

Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat

Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...

21h

Hims & Hers Sued Over Wegovy Maker’s Exit, Record Stock Selloff

Hims & Hers Health Inc. investors have sued the telehealth provider days after Novo Nordisk A/S announced it was ending the ...

Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...

Forbes3d

HIMS Stock To $25?

The collaboration between HIMS and Novo Nordisk, which began in April 2025, was supposed to be a game-changer for the telehealth company. The partnership promised direct access to Wegovy, Novo ...

4don MSN

Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drug

Novo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results